ADO

3.67%

2.1¢ anteotech ltd

DT interview 11th Feb, page-68

First 68 Last

Share
Profile

Follow
RandomGuy01

2,473 Posts.

990

12/02/21

12:46

Post #: 50931201
Share

Originally posted by pac23: ↑

Thanks for posting RG, much appreciated.

as far as Asia goes, i have been wondering what has ever come of this partnership ?

------------
ANTEO MAKES SOLID PROGRESS WITH GENEODX PARTNERSHIP

ASX Release21February 2019

HIGHLIGHTS

•GeneoDX and Anteo begin commercial discussions with three,well established,Chinese IVD and POC companies and a local subsidiary of an internationally recognised Life Sciencegroup

•Full commercial launch of AnteoBind™in China to occur next month where Anteo will have its first opportunity to broadly market its products in China•Commercial pipeline in China expected to build very rapidly.
--------

The announcement included flagging of attendance at CACLP in March2019 :

Anteo and GeneoDx will undertake a full commercial launch of the specified AnteoBind™ products at the 16thChina Association of Clinical Laboratory Practice Expo(CACLP) next month.

It is China’s largest and most influential tradeshow for the IVD industry where 800 companies exhibit and 50,000 visitors are expected.
----------------------

i doubt that there isn't any talk going on there tbh

but haven't been able to find any recent updates on the"partnership"

does anyone have any updates/ /insights on GeneoDX situation?

Expand

No idea. I only bought around mid last year shortly before it started its rise.

I'd prefer they stay out of China. It's rife with fraud, backstabbing, and IP theft.

Originally posted by slura: ↑

There’s no way that we have insufficient interest from Europe. As has been mentioned many times, the market is huge and I believe it will only be restricted by our manufacturing capacity.

Discussions for the US market have been going on for some time and that interview was probably the most bullish I’ve heard DT. He’s previously spoken of possibly licensing the test or contracting out the manufacturing like we currently doing with Operon.

I really like how confident he was with the saliva test. That will be what gets the market (both consumer and stock markets) attention. An accurate Saliva test will be worth billions IMO. Not to downplay it either but the multiplex Flu/Covid test is what will be making money for years after as Covid subsides.

That is the best and most confident that I’ve heard our CEO. This company will become a Goliath.

Expand

Totally agree. And then there's the battery side of the business.

ADO Price at posting: 21.3¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

First 68 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change -0.001(3.67%)		Mkt cap ! $52.28M

Open	High	Low	Value	Volume
2.2¢	2.3¢	2.1¢	$7.812K	349.8K

Buyers (Bids)

No.	Vol.	Price($)
7	828094	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	1102151	4

View Market Depth

No.	Vol.	Price($)
7	828094	0.021
5	1491000	0.020
2	782500	0.019
6	1986058	0.018
5	1374748	0.017

Price($)	Vol.	No.
0.022	680000	3
0.023	22000	1
0.025	40000	1
0.026	76000	2
0.027	22000	1

Last trade - 16.10pm 15/11/2024 (20 minute delay)

ADO (ASX) Chart

DT interview 11th Feb, page-68

Banshee's historic trenches prove rich in antimony and gold for GDM

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

DT interview 11th Feb, page-68

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News